Literature DB >> 16099527

HCV natural history: the retrospective and prospective in perspective.

Harvey J Alter.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16099527     DOI： 10.1016/j.jhep.2005.07.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  33 in total

Review 1.  A perspective on modelling hepatitis C virus infection.

Authors:  J Guedj; L Rong; H Dahari; A S Perelson
Journal:  J Viral Hepat       Date:  2010-08-15       Impact factor: 3.728

Review 2.  The application and mechanism of action of ribavirin in therapy of hepatitis C.

Authors:  Emmanuel Thomas; Marc G Ghany; T Jake Liang
Journal:  Antivir Chem Chemother       Date:  2012-09-25

3.  Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

Authors:  Motoyuki Kohjima; Miho Kurokawa; Munechika Enjoji; Tsuyoshi Yoshimoto; Tsukasa Nakamura; Tomoko Ohashi; Kunitaka Fukuizumi; Naohiko Harada; Yusuke Murata; Kazuhisa Matsunaga; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

4.  Metabolism and pharmacokinetics of the anti-hepatitis C virus nucleotide prodrug GS-6620.

Authors:  Eisuke Murakami; Ting Wang; Darius Babusis; Eve-Irene Lepist; Dorothea Sauer; Yeojin Park; Jennifer E Vela; Robert Shih; Gabriel Birkus; Dimitrios Stefanidis; Choung U Kim; Aesop Cho; Adrian S Ray
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

5.  Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine.

Authors:  Angela M Lam; Christine Espiritu; Eisuke Murakami; Veronique Zennou; Shalini Bansal; Holly M Micolochick Steuer; Congrong Niu; Meg Keilman; Haiying Bao; Nigel Bourne; Ronald L Veselenak; P Ganapati Reddy; Wonsuk Chang; Jinfa Du; Dhanapalan Nagarathnam; Michael J Sofia; Michael J Otto; Phillip A Furman
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

6.  Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.

Authors:  Stefano Gitto; Luca Saverio Belli; Ranka Vukotic; Stefania Lorenzini; Aldo Airoldi; Arrigo Francesco Giuseppe Cicero; Marcello Vangeli; Lucia Brodosi; Arianna Martello Panno; Roberto Di Donato; Matteo Cescon; Gian Luca Grazi; Luciano De Carlis; Antonio Daniele Pinna; Mauro Bernardi; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

7.  A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.

Authors:  Wei Hong; Yange Lang; Tian Li; Zhengyang Zeng; Yu Song; Yingliang Wu; Wenxin Li; Zhijian Cao
Journal:  J Biol Chem       Date:  2015-08-06       Impact factor: 5.157

8.  Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.

Authors:  Jiang Jingting; Wu Changping; Xu Ning; Zhu yibei; Wu Jun; Ji Mei; Xu Bin; Nilsson-Ehle Peter; Zhang Xueguan
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 9.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

10.  Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.